Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) – a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial - Behr, J; Neuser, P; Prasse, A (BMC Pulm Med, 2017)
et al.